An abstract on AHR in COVID-19 presented at the 2022 ERS International Congress reported that 43% of COVID-19 patients tested positive for MCT, which is lower than in those without COVID-19, 56% of whom exhibited MCT positivity [17]. The gene discussed is AHR; the disease is COVID-19.